BluetoothWorld hero image

2018 Sponsors

Diamond Sponsor

Thermo Fisher Scientific

thermo fisher at actss

Thermo Fisher Scientific is the world leader in serving science which uniquely positions us to partner with our customers to provide end-to-end cell therapy solutions. We understand that cell therapy is a dynamic industry with rapidly evolving technologies and processes and we are committed to helping our cell therapy customers transition from discovery to clinical research and commercial manufacturing.  Our portfolio of trusted and recognized products and services combined with over 50 years of cell culture knowledge and experience allow us to provide comprehensive solutions to support every step of the cell therapy process– from cell collection through manufacture to clinical site delivery. Through our Thermo Scientific, Applied BioSystems, Invitrogen, Fisher Scientific, Fisher BioServices, Unity Lab Services, and Gibco Cell Therapy Systems (CTS) brands, we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.

Platinum Sponsor

Miltenyi Biotec

miltenyi biotec at actss

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company is committed to enable commercial scale cell and gene therapy for the delivery of new treatment options to patients with unmet medical need. The company’s state-of-the-art technologies and products provide integrated workflows for research and clinical applications and have set a new industry standard in automated manufacturing of complex cellular products such as CAR T cells, TCR-transduced T cells, and gene-modified stem cells. Miltenyi Biotec’s portfolio of instruments, reagents and disposables is complemented with contract development and cGMP manufacturing services for lentiviral vectors and cellular products based on the company’s unique platforms for cell processing and cellular analytics.

Silver sponsor

World Courier

actss 2018 sponsor

World Courier instills confidence with logistics and supply chain programs that are in complete alignment with your business goals, as well as industry expertise and best practices, experienced personnel and global reach with local resources that ensure timely delivery, optimal handling and reduced risk for critical products.

Playing a key role in almost 16,000 clinical trials with a 99.9% success rate has helped inform World Courier’s rigorous quality standards and special handling requirements for temperature controlled shipments. Precision global logistics planning and flawless execution isn’t just a goal we set. It’s one we achieve over and over again.

When trust is absolutely essential, there’s only one choice: World Courier.

Bronze Sponsors

Oxford BioMedica

oxford biomedica ACTSS 2018 exhibitor

Oxford BioMedica is a leading gene-based biopharmaceutical company developing innovative medicines to improve the lives of patients with high unmet medical needs. We have established platform technologies in gene delivery and immunotherapy, protected by an extensive intellectual property estate. The Company's technology platform includes a highly efficient gene delivery system (LentiVector®), which has specific advantages for targeting diseases of the central nervous system and the eye; and is also widely used in the ex-vivo cell therapy arena.

Oxford BioMedica's product portfolio is focused on high value, growing markets. These include gene therapy products engineered to treat Parkinson's disease (preclinical, Phase I/II), Motor Neurone Disease (preclinical) and ocular diseases (preclinical), especially retinal diseases (Phase I and Phase I/II).

The Company also has a MHRA certified GMP manufacturing capability to produce Advanced Medicinal Products (AMP). In particular our focus is on viral manufacturing and development.


sartorius at actss

As one of the world's leading providers of laboratory and process technologies, Sartorius-Stedim enables clients around the globe to implement complex and quality-critical processes in a timely and cost-efficient manner for biopharmaceutical production and laboratory research. Through strategic alliances and acquisitions, Sartorius has amassed a portfolio of innovative products and high quality services that are now being repurposed and further refined to suit the emerging needs and intricacies of the regenerative medicine industry. With its historic roots in advancing science and next generation technologies, Sartorius aims to play an impactful role in facilitating novel technology adoption and strengthening the translational pathways for these promising new therapeutics.


savsu at actss 2018

SAVSU has develop EVO Cold Chain 2.0™ a fully integrated system developed specifically for the movement of live cells used in cell therapy, biotechnology and precision medicine applications. This system allows real time visibility of conditions and real time tracking and communication between manufacturing facilities and sites helping to reduce risk of loss in addition to increasing process efficiencies necessary for the new demands associated with cell therapies. Our complete line of high performance shippers can be used for all temperature ranges from CRT – Ln2. Working with the critical research facilities and the leading cell and gene therapy companies SAVSU is focused on helping these new therapies deliver therapeutic promise from research through to commercialization.

Associate sponsors

Be The Match BioTherapies

be the match at actss 2018

Be The Match BioTherapies® partners with organizations pursuing life-saving cellular therapies in every stage of development and is leading efforts to standardize processes that support cell therapy supply chains to ease the burden on existing infrastructure. Built on the foundation established over the last 30 years by the National Marrow Donor Program®/Be The Match®, we have unparalleled experience managing cellular therapies worldwide.

Our cell therapy supply chain for autologous and allogeneic therapies is enabled by high-touch, personalized case management teams and by MatchSource®, a robust, customizable software platform. And, we have experience building and operating large-scale cell collection networks. By leveraging our deep experience in cell sourcing and collection, we provide cells consented for research, clinical and commercial use. Through our research organization, the CIBMTR®, we are able to support the collection of cellular therapy outcomes data over time in accordance with both domestic and international regulatory requirements.

B-MoGen Biotechnologies

B-MoGen Biotechnologies PLE sponsor

B-MoGen provides cutting edge tools for gene delivery and gene editing which provide unique and powerful solutions to basic and applied research problems. Their founders have developed and licensed innovative new methods that use transposons and targeted nucleases to study human diseases and genetics in ways that are otherwise impossible. Providing tools and custom services, B-MoGen can accelerate your research and achieve what others cannot: targeting your favorite gene in your favorite cell.

Cell and Gene Therapy Catapult

cgt catapult at actss 2018

The Cell and Gene Therapy Catapult was established as an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation. With more than 170 employees focusing on cell and gene therapy technologies, it works with partners in academia and industry to ensure these life-changing therapies can be developed for use in health services throughout the world. It offers leading-edge capability, technology and innovation to enable companies to take products into clinical trials and provide clinical, process development, manufacturing, regulatory, health economics and market access expertise. Its aim is to make the UK the most compelling and logical choice for UK and international partners to develop and commercialise these advanced therapies. The Cell and Gene Therapy Catapult works with Innovate UK. For more information please visit or visit

Other sponsors


cbmg actss 2018 sponsor

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapies for the treatment of cancer and degenerative diseases. We conduct immuno-oncology and stem cell clinical trials in China using products from our integrated GMP laboratory. Our GMP facilities in China, consisting of twelve independent cell production lines, are designed and managed according to both China and U.S. GMP standards.

JiaHui Health

JiaHui Health ACTSS 2018 sponsor

Jiahui Health, established in 2009 and headquartered in Shanghai, is the first foreign-funded healthcare ecosystem in China.

Jiahui Health is devoted to building an integrated medical-teaching and research healthcare network by providing long term training for physicians and nurses, while promoting scientific research development in China.



Brooks Life Sciences

brook life sciences exhibitor at actss

Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. The global leader in automated sample management solutions we ensure cold-chain integrity from room temperature to -190° C. The company provides unparalleled experience in cold chain management that removes risk and uncertainty from your process. Offering the scale, stability, and customer support of a worldwide automation company, Brooks “future proofs” your sample workflow investment and maximizes sample availability. The company’s highly reliable, scalable systems and consumables manage sample chain of custody across a broad range of applications.


cellgenix at actss 2018

CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy space. We develop, manufacture and market human cytokines and growth factors in preclinical and GMP quality along with GMP serum-free media for further manufacturing of ATMPs. We offer our products in combination with expert regulatory and technical support to ensure a seamless transition from research to commercialization.


Fresenius Kabi

fresenius kabi ACTSS sponsor

Fresenius Kabi is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. We bring over 60 years of experience advancing the fields of cell collection and separation with expertise in closed-system processing. We recently launched Lovo, the only cell processing system that washes and concentrates white blood cells using filtration technology, specifically to serve the needs of the cellular therapies community.


trakcel exhibitor at ACTSS

A critical factor facing the industry is choosing technologies and partners that can deliver scale. The challenges inherent in translating early clinical trials to a reproducible and robust process suitable for scalable commercial production are very significant. Each personalized drug product ultimately depends on a sustainable and consistent supply chain with lots of moving parts. Configured to your exact demands, using an industry-standard framework, TrakCel’s comprehensive supply chain platform ensures every resource is managed, monitored, recorded and is ultimately performed exactly as required. From sample collection through logistics, manufacturing and final transplantation, with comprehensive chain of custody, chain of identity and traceability, TrakCel’s proven technology integrates and orchestrates every aspect of your autologous and allogeneic supply chains in a scalable, compliant and validated technology platform.